米力农对慢性充血性心力衰竭患者血清脑利钠肽的影响被引量：2

下载PDF

导出

摘要目的探讨米力农对慢性充血性心力衰竭(CHF)患者血清脑利钠肽(BNP)的影响。方法采用随机数字表法将112例CHF患者分为观察组和对照组,各56例。两组均接受常规治疗,观察组在此基础上接受静脉滴注米力农治疗,连续治疗2个疗程。于治疗前后对患者进行心功能及血清BNP检测。结果治疗前,两组左室舒张末期内径(LVIDD)、左心室射血分数(LVEF)和每搏输出量(SV)差异均无统计学意义(均P>0.05);治疗后,两组LVEF、LVIDD和SV均较治疗前显著改善(均P<0.05),且观察组优于对照组(均P<0.05)。治疗前,两组血清BNP水平差异无统计学意义(P>0.05);治疗后,观察组血清BNP水平低于对照组(P<0.05),BNP下降程度高于对照组(P<0.05)。两组均未见严重恶性心律失常、低血压等发生。结论正性肌力药米力农可降低CHF患者血清BNP水平,改善心功能,且安全性好。

作者陈娟英

机构地区湖州市南浔区练市人民医院

出处《现代实用医学》 2018年第5期607-609,共3页 Modern Practical Medicine

关键词心力衰竭充血性慢性药物疗法米力农脑利钠肽

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1贺淑媛,李江林,杨超,叶喜阳.米力农治疗慢性充血性心力衰竭急性加重期的临床观察[J].中国药房,2015,26(15):2075-2077. 被引量：12
2冉崇云.米力农对慢性充血性心力衰竭患者B型脑钠素的影响[J].中国现代医生,2015,53(23):98-100. 被引量：5
3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量：3717
4胡志良.米力农对充血性心力衰竭患者心功能及脑钠肽水平的影响[J].当代医学,2017,23(3):63-64. 被引量：6
5廖然.米力农联合小剂量美托洛尔治疗充血性心力衰竭的临床疗效观察[J].实用心脑肺血管病杂志,2015,23(3):56-58. 被引量：5
6邹晓光,朱永艳,张治成,陈红霞,管喜峰.米力农对慢性充血性心力衰竭老年患者心功能及血气分析指标的影响[J].中华老年医学杂志,2017,36(11):1176-1179. 被引量：20
7蒋伏平,龚和禾,陈霓红,朱琪,庄世虹.米力农对老年充血性心力衰竭患者心功能及血浆NT-pro-BNP水平的影响[J].中国老年学杂志,2013,33(24):6250-6251. 被引量：26
8李雅男,苏鹏宇.米力农和左西孟旦对失代偿心力衰竭患者脑利钠肽水平和心功能的影响比较[J].中国药业,2016,25(17):53-56. 被引量：14

二级参考文献105

1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：91
2林劲,翟任群,吴明.贝那普利与美托洛尔联用治疗慢性充血性心力衰竭的临床观察[J].中国基层医药,2006,13(12):1953-1955. 被引量：5
3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.